Generics
Samsung Bioepis partners with Sandoz on up to five next-generation biosimilars
18 March 2026 - South Korean biopharmaceutical company Samsung Bioepis Co Ltd on Wednesday announced a global development and commercialisation agreement with Sandoz Group AG (SIX:SDZ), a generics and...
Breckenridge Pharmaceutical partners with sterile injectable manufacturer Maiva Pharma
12 March 2026 - Breckenridge Pharmaceutical Inc, the US subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, on Wednesday announced a new partn...
Breckenridge Pharmaceutical launches Pomalidomide Capsules in US market
3 March 2026 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International, announced on Monday the launch of Pomalidomide Capsules, a generic version of Pomalyst by Celgene (...
Cipla launches generic liraglutide injection in the US
...
Arna Pharma signs MOU with Slate Run Pharmaceuticals
27 February 2026 - Arna Pharma Inc, an Australia-based global pharmaceutical company, and US-based Slate Run Pharmaceuticals, announced on Thursday that they have signed an MOU to establish a scaled-u...
STADA and Bio-Thera Solutions receive European marketing authorisation for Gotenfia (golimumab)
16 February 2026 - Specialty, generic and consumer healthcare medicines company STADA and Bio-Thera Solutions (SH:688177), a commercial-stage biopharmaceutical company, announced on Friday that they h...